Loading...

OSTEOPETROSIS GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Osteopetrosis Gene Panel by NGS is a specialized genetic test designed to detect mutations responsible for various forms of osteopetrosis, a rare disorder characterized by abnormally dense and fragile bones. Metropolis Healthcare utilizes advanced Next-Generation Sequencing (NGS) to analyze multiple genes involved in bone resorption and remodeling. This test supports early and accurate diagnosis, helps classify the disease subtype, and aids clinicians in planning appropriate management. It is especially valuable for individuals with fractures, anemia, growth issues, or a family history of osteopetrosis 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0235

Frequently Asked Questions (FAQ's):

What does the Osteopetrosis Gene Panel include?
It includes comprehensive genetic sequencing performed by Metropolis Healthcare to identify mutations linked to osteopetrosis.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-resolution NGS technology to analyze bone-remodeling genes from an EDTA blood sample.

Who should take this test?
Individuals with unexplained bone density abnormalities, recurrent fractures, anemia, or suspected inherited bone disorders may benefit.

Can this test determine the subtype of osteopetrosis?
Yes, identifying specific gene mutations helps classify the condition and guide prognosis.

What sample is required for this test?
An EDTA blood sample is required for DNA extraction and detailed gene analysis.

Is this test helpful for family counseling?
Yes, genetic confirmation supports assessment of inheritance patterns and risks for future pregnancies.

How long does Metropolis Healthcare take to deliver results?
Results generally take a few weeks due to detailed sequencing and interpretation.

Does this test guide treatment decisions?

Yes, understanding the genetic cause helps clinicians plan monitoring, supportive care, and potential treatment options such as stem cell evaluation 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab